Show simple item record

dc.contributor.authorTraver, Edward C.
dc.contributor.authorMelanie Malave, Sánchez
dc.date.accessioned2023-11-09T17:34:07Z
dc.date.available2023-11-09T17:34:07Z
dc.date.issued2022-01-06
dc.identifier.urihttp://hdl.handle.net/10713/21041
dc.descriptionThe article processing charges (APC) for this open access article were partially funded by the Health Sciences and Human Services Library's Open Access Publishing Fund for Early-Career Researchers.en_US
dc.description.abstractInvasive fungal infections may complicate infection by SARS-CoV-2 and increase morbidity and mortality. A 59- year-old man with multiple medical comorbidities was transferred to our hospital for worsening hypoxic respiratory failure due to COVID-19 and received high-dose corticosteroids and 2 doses of cyclophosphamide. He was diagnosed with pulmonary aspergillosis and cryptococcosis by culture of a bronchoalveolar lavage sample. This patient’s secondary infections were likely due to treatment with immunosuppressants, his comorbidities, and his prolonged critical illness.en_US
dc.language.isoen_USen_US
dc.relation.ispartofMedical Mycology Case Reportsen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshSARS-CoV-2en_US
dc.subject.meshCOVID-19en_US
dc.subject.meshAspergillusen_US
dc.subject.meshCryptococcusen_US
dc.titlePulmonary aspergillosis and cryptococcosis as a complication of COVID-19en_US
dc.typeArticleen_US
refterms.dateFOA2023-11-09T17:34:08Z


Files in this item

Thumbnail
Name:
Traver_Edward_APC_2022.pdf
Size:
479.9Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International